| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 26,089 | 16,084 |
| Provision for credit losses | 1,875 | 1,375 |
| Depreciation and amortization | 1,414 | 921 |
| Amortization and accretion of loans and other assets | 2,691 | 1,691 |
| Amortization and accretion of investment securities | -547 | -430 |
| Deferred income taxes | 547 | 623 |
| Equity securities gains, net | 56 | 21 |
| Earnings on bank owned life insurance | 1,064 | 701 |
| Vesting of restricted stock | 296 | 243 |
| Originations of loans held for sale | 117,364 | 73,045 |
| Proceeds from sales of loans held for sale | 115,131 | 68,109 |
| Realized gains on loans sold | 1,720 | 1,011 |
| Realized gains on sale of braavo | 0 | 0 |
| (increase) decrease in accrued interest receivable | 1,105 | 296 |
| Loss on sale of foreclosed assets held for sale | 9 | - |
| (decrease) increase in accrued interest payable | -939 | -1,952 |
| Other, net | -1,147 | 7,861 |
| Net cash provided by operating activities | 19,804 | 16,929 |
| Proceeds from maturity and principal repayments | 55,149 | 33,486 |
| Purchase of securities | 68,404 | 35,282 |
| Proceeds from sale of equity securities | 0 | 0 |
| Purchase of interest bearing time deposits with other banks | 0 | 0 |
| Proceeds from matured interest bearing time deposits with other banks | 0 | 0 |
| Proceeds from life insurance | 272 | 272 |
| Proceeds from redemption of regulatory stock | 24,124 | 16,397 |
| Purchase of regulatory stock | 24,290 | 17,146 |
| Net increase in loans | 19,386 | -73,137 |
| Purchase of premises and equipment | 1,225 | 1,080 |
| Proceeds from sale of premises and equipment | 13 | 12 |
| Proceeds from sale of foreclosed assets held for sale | 170 | 170 |
| Proceeds from sale of braavo assets | 0 | 0 |
| Net cash used in investing activities | -33,577 | 69,966 |
| Net increase in deposits | 29,175 | -89,366 |
| Repayments of long-term borrowings | 37,000 | 10,000 |
| Net increase (decrease) in short-term borrowed funds | 17,942 | 24,760 |
| Purchase of treasury and restricted stock | 373 | 296 |
| Sale of stock for espp | 48 | 32 |
| Dividends paid | 7,146 | 4,743 |
| Net cash provided by financing activities | 2,646 | -79,613 |
| Net decrease in cash and cash equivalents | -11,127 | 7,282 |
| Cash and cash equivalents at beginning of period | 42,202 | - |
| Cash and cash equivalents at end of period | 31,075 | - |
CITIZENS FINANCIAL SERVICES INC (CZFS)
CITIZENS FINANCIAL SERVICES INC (CZFS)